Search research articles
Contact Us
Filters
Showing results (111-120 of 145) with videos related to
Page
of 15
Sort By:
Aging Cell
|
June 12, 2021
Circulating microRNA profile in humans and mice with congenital GH deficiency
Tatiana D Saccon, Augusto Schneider, Cindi G Marinho, et al.
Age (Dordrecht, Netherlands)
|
September 3, 2016
Pioglitazone is equally effective for diabetes prevention in older versus younger adults with impaired glucose tolerance
Sara E Espinoza, Chen-Pin Wang, Devjit Tripathy, et al.
Research Square
|
September 16, 2024
ATM phosphorylation of CD98HC increases antiporter membrane localization and prevents chronic toxic glutamate accumulation in Ataxia telangiectasia
Alexander Bishop, July Carolina Romero, Sonal Tonapi, et al.
American Journal of Physiology. Endocrinology and Metabolism
|
January 26, 2006
Exercise training decreases the concentration of malonyl-CoA and increases the expression and activity of malonyl-CoA decarboxylase in human muscle
Jeanette E Kuhl, Neil B Ruderman, Nicolas Musi, et al.
Communications Medicine
|
May 20, 2025
Rapamycin treatment for Alzheimer's disease and related dementias: a pilot phase 1 clinical trial
Mitzi M Gonzales, Valentina R Garbarino, Tiffany F Kautz, et al.
Hepatology (Baltimore, Md.)
|
February 20, 2018
DEP domain-containing mTOR-interacting protein suppresses lipogenesis and ameliorates hepatic steatosis and acute-on-chronic liver injury in alcoholic liver disease
Hanqing Chen, Feng Shen, Alex Sherban, et al.
Cell Reports
|
May 13, 2014
APPL1 potentiates insulin sensitivity by facilitating the binding of IRS1/2 to the insulin receptor
Jiyoon Ryu, Amanda K Galan, Xiaoban Xin, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
November 24, 2012
Pioglitazone slows progression of atherosclerosis in prediabetes independent of changes in cardiovascular risk factors
Aramesh Saremi, Dawn C Schwenke, Thomas A Buchanan, et al.
NPJ Dementia
|
March 19, 2025
A Phase IIa clinical trial to evaluate the effects of anti-retroviral therapy in Alzheimer's disease (ART-AD)
A Campbell Sullivan, Gabrielle Zuniga, Paulino Ramirez, et al.
Medrxiv : the Preprint Server for Health Sciences
|
March 11, 2024
A pilot study to investigate the safety and feasibility of antiretroviral therapy for Alzheimer's disease (ART-AD)
A Campbell Sullivan, Gabrielle Zuniga, Paulino Ramirez, et al.
Page
of 15
Search research articles
Search
Showing results (111-120 of 145) with videos related to
Sort By:
Page
of 15
Aging Cell
|
June 12, 2021
Circulating microRNA profile in humans and mice with congenital GH deficiency
Tatiana D Saccon, Augusto Schneider, Cindi G Marinho, et al.
Age (Dordrecht, Netherlands)
|
September 3, 2016
Pioglitazone is equally effective for diabetes prevention in older versus younger adults with impaired glucose tolerance
Sara E Espinoza, Chen-Pin Wang, Devjit Tripathy, et al.
Research Square
|
September 16, 2024
ATM phosphorylation of CD98HC increases antiporter membrane localization and prevents chronic toxic glutamate accumulation in Ataxia telangiectasia
Alexander Bishop, July Carolina Romero, Sonal Tonapi, et al.
American Journal of Physiology. Endocrinology and Metabolism
|
January 26, 2006
Exercise training decreases the concentration of malonyl-CoA and increases the expression and activity of malonyl-CoA decarboxylase in human muscle
Jeanette E Kuhl, Neil B Ruderman, Nicolas Musi, et al.
Communications Medicine
|
May 20, 2025
Rapamycin treatment for Alzheimer's disease and related dementias: a pilot phase 1 clinical trial
Mitzi M Gonzales, Valentina R Garbarino, Tiffany F Kautz, et al.
Hepatology (Baltimore, Md.)
|
February 20, 2018
DEP domain-containing mTOR-interacting protein suppresses lipogenesis and ameliorates hepatic steatosis and acute-on-chronic liver injury in alcoholic liver disease
Hanqing Chen, Feng Shen, Alex Sherban, et al.
Cell Reports
|
May 13, 2014
APPL1 potentiates insulin sensitivity by facilitating the binding of IRS1/2 to the insulin receptor
Jiyoon Ryu, Amanda K Galan, Xiaoban Xin, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
November 24, 2012
Pioglitazone slows progression of atherosclerosis in prediabetes independent of changes in cardiovascular risk factors
Aramesh Saremi, Dawn C Schwenke, Thomas A Buchanan, et al.
NPJ Dementia
|
March 19, 2025
A Phase IIa clinical trial to evaluate the effects of anti-retroviral therapy in Alzheimer's disease (ART-AD)
A Campbell Sullivan, Gabrielle Zuniga, Paulino Ramirez, et al.
Medrxiv : the Preprint Server for Health Sciences
|
March 11, 2024
A pilot study to investigate the safety and feasibility of antiretroviral therapy for Alzheimer's disease (ART-AD)
A Campbell Sullivan, Gabrielle Zuniga, Paulino Ramirez, et al.
Page
of 15